Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Contraception and Contraceptive Drugs

Free Subscription Articles published in Biochem Biophys Res Commun Retrieve available abstracts of 6 articles: HTML format

Single Articles

November 2022
1. CARTWRIGHT M, Toit RL, Africander D
   The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor.
   Biochem Biophys Res Commun. 2022;639:70-76.
   PubMed     Abstract available
   
   
   
2. OMAR IS, Mat Adenan NA, Godoy A, Teo IH, et al
   Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium.
   Biochem Biophys Res Commun. 2022;628:133-140.
   PubMed     Abstract available
   
   
   November 2021
3. DAS A, Bysack A, Raghuraman H
   Effectiveness of dual-detergent strategy using Triton X-100 in membrane protein purification.
   Biochem Biophys Res Commun. 2021;578:122-128.
   PubMed     Abstract available
   
   
   April 2021
4. DING F, Qiu C, Li W, Liu Z, et al
   CNR1 may reverse progesterone-resistance of endometrial cancer through the ERK pathway.
   Biochem Biophys Res Commun. 2021;548:148-154.
   PubMed     Abstract available
   
   
   December 2020
5. ENFIELD K, Dlamini S, Avenant C, Kuipa M, et al
   Maraviroc, tenofovir disoproxil fumarate and dapivirine, activate progesterone receptor B in the absence of progestogens.
   Biochem Biophys Res Commun. 2020;533:1027-1033.
   PubMed     Abstract available
   
   
   September 2020
6. ENFIELD K, Cartwright M, Toit RL, Avenant C, et al
   Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor.
   Biochem Biophys Res Commun. 2020 Sep 29. pii: S0006-291X(20)31799.
   PubMed     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: